Glucose + Nacl B. Braun (Sodium Chloride, Glucose Monohydrate)

Glucose + NaCl B. Braun is used when patients need rapid restoration of fluid volume, electrolytes, and an energy source. It is commonly administered in hospitals and other healthcare facilities.

• Fluid replacement in dehydration or blood loss
• Electrolyte replenishment, especially sodium deficits
• Provision of an immediate carbohydrate source for metabolic support
• Adjunct to parenteral nutrition regimens
• Support during surgical procedures or anesthesia
• Management of hypoglycemia when combined with glucose delivery

Side effects may occur with any intravenous solution, though many patients tolerate the product without issues.

Common

• Mild infusion site irritation or erythema
• Transient hyperglycemia
• Slight increase in serum sodium levels
• Nausea or mild gastrointestinal discomfort
• Headache or dizziness
• Low-grade fever

Serious

• Severe hypernatremia leading to neurologic symptoms
• Significant hyperglycemia requiring medical intervention
• Allergic reaction such as urticaria or anaphylaxis
• Fluid overload causing pulmonary edema
• Electrolyte imbalance with severe hyponatremia or hyperkalemia
• Hemolysis in patients with incompatible solutions

Healthcare professionals should assess patient-specific factors before administering Glucose + NaCl B. Braun.

• Verify serum electrolyte and glucose levels prior to infusion
• Adjust infusion rate in patients with cardiac or renal insufficiency
• Use caution in neonates, infants, and the elderly due to altered fluid balance
• Monitor for signs of fluid overload, especially in postoperative patients
• Avoid rapid administration in patients at risk for cerebral edema
• Ensure compatibility with other intravenous medications before mixing
• Document any adverse reactions and report to pharmacovigilance systems

Glucose + NaCl B. Braun may interact with other intravenous therapies or systemic medications.

Avoid

• Co-administration with hypertonic saline solutions that could exacerbate hypernatremia
• Simultaneous infusion of potassium chloride without proper monitoring, risking hyperkalemia
• Use with drugs that cause fluid retention, such as corticosteroids, without dose adjustment

Use with caution

• Concurrent insulin therapy, as glucose infusion may affect glycemic control
• Diuretics, which can alter electrolyte balance during fluid replacement
• Antihypertensive agents, especially ACE inhibitors, due to potential changes in volume status
• Medications affecting renal function, such as NSAIDs, requiring close monitoring of electrolytes